US Patent 9169246 Pyrazoloquinolinone derivatives, preparation thereof and therapeutic use thereof

Patent 9169246 was granted and assigned to Sanofi on October, 2015 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Sanofi

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

9169246

Date of Patent

October 27, 2015

Patent Application Number

13245468

Date Filed

September 26, 2011

Patent Citations Received

‌

US Patent 11767320 Bicyclic dione compounds as inhibitors of KRAS

‌

US Patent 12077539 Imidazole and triazole KRAS inhibitors

‌

US Patent 11999752 Vinyl imidazole compounds as inhibitors of KRAS

‌

US Patent 11939328 Quinoline compounds as inhibitors of KRAS

Patent Primary Examiner

‌

Rita Desai

Patent abstract

The invention relates to compounds corresponding to formula (I)

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9169246 Pyrazoloquinolinone derivatives, preparation thereof and therapeutic use thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API